Annals of Surgical Oncology

, Volume 18, Issue 13, pp 3797–3801 | Cite as

The Safety of Multiple Re-excisions after Lumpectomy for Breast Cancer

  • Suzanne Coopey
  • Barbara L. Smith
  • Stephanie Hanson
  • Julliette Buckley
  • Kevin S. Hughes
  • Michele Gadd
  • Michelle C. Specht
Breast Oncology



Breast cancer patients may undergo multiple re-excisions after lumpectomy in an attempt to obtain clear margins and avoid mastectomy. We sought to determine the overall local recurrence rate and surgical outcome of patients undergoing two or more re-excisions and to identify predictors of success in attaining clear margins.


Retrospective review of breast cancer patients who underwent lumpectomy for invasive cancer or ductal carcinoma in situ (DCIS) from 1997 to 2007. Patients who underwent two or more re-excisions were identified and analyzed.


We identified 3,737 patients who underwent lumpectomy over this 10-year period. 875 (23.4%) had close or positive margins requiring a second procedure; 797 (91.1%) had a re-excision; and 78 (8.9%) went directly to mastectomy. Seventy patients underwent multiple re-excisions; 66 patients had 2 re-excisions, 3 patients had 3 re-excisions, and 1 patient had 4 re-excisions. 70% (49/70) of multiple re-excision patients achieved clear margins (26 DCIS, 35 T1, 8 T2, and 1 T3 tumors). All 49 patients who successfully treated with multiple re-excisions received radiation. At a median follow-up of 64 months, 1 of 49 (2.0%) patients had an in-breast recurrence, and 1 of 49 (2.0%) patients had a distant recurrence. Statistically significant risk factors for persistently involved margins after two re-excisions included multifocality and positive lymph node status.


Multiple re-excisions to obtain clear margins are a safe alternative to mastectomy for women with invasive cancer or DCIS. There is an acceptably low risk of local and systemic failure when negative margins are ultimately achieved.


Positive Margin Local Recurrence Rate Invasive Lobular Carcinoma Negative Margin Clear Margin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Arriagada R, Le MG, Rochard F, Contesso G for the Institut Gustave-Roussy Breast Cancer Group. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol. 1996;14:1558–64.PubMedGoogle Scholar
  2. 2.
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRefGoogle Scholar
  3. 3.
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRefGoogle Scholar
  4. 4.
    Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668–75.PubMedGoogle Scholar
  5. 5.
    Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002;184:383–93.PubMedCrossRefGoogle Scholar
  6. 6.
    Kreike B, Hart AAM, Van de Velde T, et al. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;71:1014–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Smitt MC, Nowels K, Carlson RW, Jeffrey SS. Predictors of reexcision findings and recurrence after breast conservations. Int J Radiat Oncol Biol Phys. 2003;57:979–85.PubMedCrossRefGoogle Scholar
  8. 8.
    Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999;44:1005–15.PubMedCrossRefGoogle Scholar
  9. 9.
    Schiller DE, Le LW, Cho CJ, Youngson BJ, McCready DR. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol. 2008;15:833–42.PubMedCrossRefGoogle Scholar
  10. 10.
    Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol. 2008;15:1297–303.PubMedCrossRefGoogle Scholar
  11. 11.
    Kurniawan ED, Wong MH, Windle I, et al. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol. 2008;15:2542–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Dillon MF, Hill ADK, Quinn CM, McDermott EW, O’Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol. 2006;13:333–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Smitt MC, Horst K. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive cancer. Ann Surg Oncol. 2007;14:1040–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Keskek M, Kothari M, Ardehali B, Betambeau N, Nasiri N, Gui GPH. Factors predisposing to cavity margin positivity following conservation surgery for breast cancer. EJSO. 2004;30:1058–64.PubMedGoogle Scholar
  15. 15.
    Cellini C, Hollenbeck ST, Christos P, et al. Factors associated with residual breast cancer after re-excision for close or positive margins. Ann Surg Oncol. 2004;11:915–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Sabel MS, Rogers K, Griffith K, et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol. 2009;99:99–103.PubMedCrossRefGoogle Scholar
  17. 17.
    Cellini C, Huston TL, Martins D, Christos P, Carson J, Kemper S, Simmons RM. Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conserving surgery. Am J Surg. 2005;189:662–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Menes TS, Tartter PI, Bleiweiss I, Godbold JH, Estabrook A, Smith SR. The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol. 2005;12:881–5.PubMedCrossRefGoogle Scholar
  19. 19.
    O’Sullivan MJ, Li T, Freedman G, Morrow M. The effect of multiple re-excisions on the risk of local recurrence after breast conserving surgery. Ann Surg Oncol. 2007;14:3133–40.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2011

Authors and Affiliations

  • Suzanne Coopey
    • 1
  • Barbara L. Smith
    • 1
  • Stephanie Hanson
    • 1
  • Julliette Buckley
    • 1
  • Kevin S. Hughes
    • 1
  • Michele Gadd
    • 1
  • Michelle C. Specht
    • 1
  1. 1.Department of Surgical OncologyMassachusetts General HospitalBostonUSA

Personalised recommendations